| scholarly article | Q13442814 |
| P2093 | author name string | Hui Liu | |
| Yang Yang | |||
| Yao Li | |||
| Pei Li | |||
| Qi-Wei Jiang | |||
| Jin Ye | |||
| Zhi Shi | |||
| Jia-Rong Huang | |||
| Meng-Ning Wei | |||
| Meng-Ling Yuan | |||
| Xi-Jun Lin | |||
| Zi-Hao Xing | |||
| Man-Man Zou | |||
| P2860 | cites work | Evolutionary dynamics of cancer in response to targeted combination therapy | Q21128788 |
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Targeting microRNAs as key modulators of tumor immune response | Q26746972 | ||
| CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity | Q26782520 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Recent Advances in Immunotherapy in Metastatic NSCLC | Q28069323 | ||
| Enhancement of sensitivity to tumor necrosis factor alpha in non-small cell lung cancer cells with acquired resistance to gefitinib | Q40338930 | ||
| Oxymatrine lightened the inflammatory response of LPS-induced mastitis in mice through affecting NF-κB and MAPKs signaling pathways | Q42205626 | ||
| MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1 | Q42328100 | ||
| Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade. | Q47799445 | ||
| H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo. | Q50170666 | ||
| Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer | Q83176803 | ||
| Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer | Q83761844 | ||
| CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes | Q84474625 | ||
| Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer | Q28082255 | ||
| The roles of IFN gamma in protection against tumor development and cancer immunoediting | Q28207895 | ||
| Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship | Q28278682 | ||
| Mechanisms of foxp3+ T regulatory cell-mediated suppression | Q29615842 | ||
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways. | Q33638975 | ||
| T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model | Q33683128 | ||
| Anti‑inflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells | Q33702253 | ||
| A fresh look at tumor immunosurveillance and immunotherapy. | Q33940160 | ||
| Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer | Q34210036 | ||
| T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor | Q34709824 | ||
| MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth | Q34899627 | ||
| miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines. | Q34985536 | ||
| Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer | Q35920693 | ||
| Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer | Q36537920 | ||
| Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine. | Q36544979 | ||
| Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy | Q36723728 | ||
| The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder | Q37012561 | ||
| MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer | Q37210788 | ||
| microRNA-155 deficiency impairs dendritic cell function in breast cancer | Q37477262 | ||
| Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo | Q37587330 | ||
| CD8(+) T cells: foot soldiers of the immune system | Q37922333 | ||
| miR-155: an ancient regulator of the immune system | Q38095500 | ||
| Anti-tumor activities of matrine and oxymatrine: literature review | Q38187919 | ||
| Mir-155, a central modulator of T-cell responses. | Q38191232 | ||
| Therapeutic targeting of microRNAs: current status and future challenges | Q38228101 | ||
| Chemotherapy in Metastatic NSCLC - New Regimens (Pemetrexed, Nab-Paclitaxel) | Q38237655 | ||
| Lung cancer in 2014: optimizing lung cancer treatment approaches | Q38297888 | ||
| Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases. | Q38395045 | ||
| Regulatory T cells and potential inmmunotherapeutic targets in lung cancer | Q38473314 | ||
| Refining the treatment of NSCLC according to histological and molecular subtypes | Q38473472 | ||
| MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR. | Q38652482 | ||
| Roles of regulatory T cells in cancer immunity | Q38830072 | ||
| Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity | Q39234961 | ||
| Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. | Q39579366 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cisplatin | Q412415 |
| non-small-cell lung carcinoma | Q3658562 | ||
| P304 | page(s) | 631 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8 T Cells in Non-small Cell Lung Cancer | |
| P478 | volume | 8 |
| Q89795557 | TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer |
| Q92324655 | Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLC |
| Q89966997 | miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78 |
Search more.